S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
Warren Buffett uses his annual letter to warn about Wall Street and recount Berkshire's successes
Wall Street Pushing a 'Crypto Revolution' - Will You Miss Out… AGAIN? (Ad)
MarketBeat Week in Review – 2/19 - 2/23
A collection of the insights Warren Buffett offered in his annual letter Saturday
Elon Musk's "Project Dojo" is a Game-Changer (Ad)
West Africa bloc lifts coup sanctions on Niger in a new push for dialogue to resolve tensions
West Africa's ECOWAS bloc says it's lifting sanctions imposed on Niger over last year’s coup in a new push for dialogue
Elon Musk's "Project Dojo" is a Game-Changer (Ad)
Macron booed by French farmers who blame him for not doing enough to support agriculture
MILAN FASHION PHOTOS: Ferragamo, Dolce&Gabbana conceal and reveal, balance transparency with cover
S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
Warren Buffett uses his annual letter to warn about Wall Street and recount Berkshire's successes
Wall Street Pushing a 'Crypto Revolution' - Will You Miss Out… AGAIN? (Ad)
MarketBeat Week in Review – 2/19 - 2/23
A collection of the insights Warren Buffett offered in his annual letter Saturday
Elon Musk's "Project Dojo" is a Game-Changer (Ad)
West Africa bloc lifts coup sanctions on Niger in a new push for dialogue to resolve tensions
West Africa's ECOWAS bloc says it's lifting sanctions imposed on Niger over last year’s coup in a new push for dialogue
Elon Musk's "Project Dojo" is a Game-Changer (Ad)
Macron booed by French farmers who blame him for not doing enough to support agriculture
MILAN FASHION PHOTOS: Ferragamo, Dolce&Gabbana conceal and reveal, balance transparency with cover
S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
Warren Buffett uses his annual letter to warn about Wall Street and recount Berkshire's successes
Wall Street Pushing a 'Crypto Revolution' - Will You Miss Out… AGAIN? (Ad)
MarketBeat Week in Review – 2/19 - 2/23
A collection of the insights Warren Buffett offered in his annual letter Saturday
Elon Musk's "Project Dojo" is a Game-Changer (Ad)
West Africa bloc lifts coup sanctions on Niger in a new push for dialogue to resolve tensions
West Africa's ECOWAS bloc says it's lifting sanctions imposed on Niger over last year’s coup in a new push for dialogue
Elon Musk's "Project Dojo" is a Game-Changer (Ad)
Macron booed by French farmers who blame him for not doing enough to support agriculture
MILAN FASHION PHOTOS: Ferragamo, Dolce&Gabbana conceal and reveal, balance transparency with cover
S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
Warren Buffett uses his annual letter to warn about Wall Street and recount Berkshire's successes
Wall Street Pushing a 'Crypto Revolution' - Will You Miss Out… AGAIN? (Ad)
MarketBeat Week in Review – 2/19 - 2/23
A collection of the insights Warren Buffett offered in his annual letter Saturday
Elon Musk's "Project Dojo" is a Game-Changer (Ad)
West Africa bloc lifts coup sanctions on Niger in a new push for dialogue to resolve tensions
West Africa's ECOWAS bloc says it's lifting sanctions imposed on Niger over last year’s coup in a new push for dialogue
Elon Musk's "Project Dojo" is a Game-Changer (Ad)
Macron booed by French farmers who blame him for not doing enough to support agriculture
MILAN FASHION PHOTOS: Ferragamo, Dolce&Gabbana conceal and reveal, balance transparency with cover
LON:AGY

Allergy Therapeutics (AGY) Share Price, News & Analysis

GBX 2.60
0.00 (0.00%)
(As of 02/23/2024 ET)
Today's Range
2.50
2.70
50-Day Range
2
2.60
52-Week Range
0.80
3.90
Volume
113,064 shs
Average Volume
855,447 shs
Market Capitalization
£124.02 million
P/E Ratio
N/A
Dividend Yield
8.33%
Price Target
N/A

AGY stock logo

About Allergy Therapeutics Stock (LON:AGY)

Allergy Therapeutics plc, a commercial biotechnology company, engages in the research and development of allergy treatments. The company sells injectable and sublingual allergen-specific immunotherapies; and offers prescription for the treatment of pollen-related allergies particularly to grasses, weeds, and trees, as well as diagnostics. Its products include Pollinex Quattro, Oralvac, Venomil, Venom ATL Polistes Dominula, Acarovac Plus, Pollinex, Synbiotics, and VLP Peanut. The company develops allergy vaccines for pollen, house dust mites, and animal fur, as well as peanut allergy vaccines. It operates in Central Europe, Southern Europe, the United Kingdom, and internationally. Allergy Therapeutics plc was incorporated in 2004 and is headquartered in Worthing, the United Kingdom.

AGY Stock Price History

AGY Stock News Headlines

Allergy Therapeutics PLC AGY
The perfect AI stock under $10
Normally, bringing a new drug to market takes an average of 10 years and between $2.5 and $12 billion. However, new AI technology has the potential to make the process up to 1000 times faster. This #1 AI company is at the forefront of it all.
Claim $10,000 In FREE silver In 2024
Thanks to forgotten 50-year-old legislation, often ignored by investment advisors, gold bugs, and silver hounds…You can now collect $10,000 or more in free silver. Millions of Americans know NOTHING about this…Because it exploits a “glitch” in the IRS tax code that helps protect your retirement...While paying ZERO TAXES & PENALTIES to do it. That’s why you need to see this NOW.
Form 8.3 - The Allergy Therapeutics Plc
Allergy Diagnostics And Therapeutics Market by 2031
See More Headlines
Receive AGY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Allergy Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
3/04/2020
Today
2/25/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
612
Year Founded
N/A

Profitability

Net Income
£-43,070,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£59.59 million
Cash Flow
GBX 0.71 per share

Miscellaneous

Outstanding Shares
4,770,000,000
Free Float
N/A
Market Cap
£124.02 million
Optionable
Not Optionable
Beta
1.28
The 10 Best AI Stocks to Own in 2024 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Key Executives

  • Mr. Manuel Llobet (Age 60)
    CEO & Executive Director
    Comp: $411.98k
  • Mr. Shaun Furlong
    Chief Financial Officer
  • Ms. Beverly Lees
    Group Operations Director
  • Dr. Murray Skinner
    Chief Scientific Officer
  • Mr. Santiago Puig
    Business Development Director
  • Ms. Sue Baker
    Head of Human Resources
  • Simon Piggott
    Head of Clinical Science
  • Alan Bullimore
    Head of Communication & Market Development
  • Mr. Russell Picket
    Group Financial Controller
  • Karley Charlotte Mouatt Cheesman
    Company Secretary














AGY Stock Analysis - Frequently Asked Questions

How have AGY shares performed in 2024?

Allergy Therapeutics' stock was trading at GBX 2.50 at the beginning of 2024. Since then, AGY stock has increased by 4.0% and is now trading at GBX 2.60.
View the best growth stocks for 2024 here
.

How were Allergy Therapeutics' earnings last quarter?

Allergy Therapeutics plc (LON:AGY) released its quarterly earnings data on Wednesday, March, 4th. The company reported $2.40 EPS for the quarter. Allergy Therapeutics had a negative trailing twelve-month return on equity of 216.27% and a negative net margin of 72.28%.

What other stocks do shareholders of Allergy Therapeutics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Allergy Therapeutics investors own include (RLYP) (RLYP), Royalty Pharma (RPRX), Verastem (VSTM), Berkeley Energia (BKY), Burford Capital (BUR), Direxion Daily Gold Miners Index Bear 2x Shares (DUST), Flowtech Fluidpower (FLO), Merrimack Pharmaceuticals (MACK) and Shanta Gold (SHG).

How do I buy shares of Allergy Therapeutics?

Shares of AGY stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

This page (LON:AGY) was last updated on 2/25/2024 by MarketBeat.com Staff